Abstract
Lung cancer is the second most commonly diagnosed type of cancer worldwide. Approximately 85% of patients with lung cancer have non-small cell lung cancer (NSCLC). Since 2015, patients with advanced NSCLC can be treated with immunotherapy, which supports the patient’s own immune system in killing cancer cells by blocking the
... read more